SEMAGLUTIDE and TIRZEPATIDE – THE BEST WEIGHT LOSS DRUGS

Weight loss drugs used to get a bad rap. Over the years, the results were lackluster and the side effects could be dangerous. However, when the category of drugs called GLP1s came to market everything changed for the better. The first drug Semaglutide brand Wegovy came to market first as a diabetic drug in 2017 under the name Ozempic. Use of this drug lowers sugar levels and helps patients lose up to 20 percent of their weight. The pharmaceutical company rebranded the drug as Wegovy in 2021 sold as a once a week injection for weight loss only. The brand drug Wegovy comes in strengths 0.25 mg to 2.4 mg as does the generic Semaglutide. The brand name drug manufacturer Novo Nordisk did a study showing that half the participants were able to lose 15 percent of their body weight, and nearly a third lost 20 percent of their body weight.

 

Eventually drug manufacturer Lilly came out with brand drug Tirzepatide in 2023 called Zepbound for weight loss and obesity. Tirzepatide is stronger than Semaglutide and patients noticed faster and more improved results.

 

At my practice, I can prescribe brand Wegovy and brand Zepbound only if a patient’s insurance covers it. The patient has to have a BMI over 30 and possibly other health conditions. We also prescribe generic Seamglutide injections, Generic Tirzepatide injections, and now oral disintegrating tablets for Tirzepatide. The advantage of the generics is they are much more affordable and have a much better side effect profile. Also, patients can titrate the dosing of the generics to their perfect advantage. Please call our office if you are interested in starting a healthy and promising weight loss journey